| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology. |
From the Department of Neurological Sciences, Rush Medical College, Rush Epilepsy Center, Rush-Presbyterian St. Luke’s Medical Center, Chicago, IL.
Address correspondence and reprint requests to Dr. Andres M. Kanner, Department of Neurological Sciences, Rush–Presbyterian St. Luke’s Medical Center, 1653 West Congress Parkway, Chicago, IL 60612.
Article abstract Depressive disorders (DDs) are the most common type of psychiatric co-morbidity in patients with epilepsy. They are more likely to occur in patients with partial seizure disorders of temporal and frontal lobe origin and are more frequent among patients with poorly controlled seizures. Despite their relatively high prevalence, DDs remain unrecognized and untreated in a large proportion of patients. This article highlights the evidence of a close association between DDs and epilepsy, beginning with the bi-directional relationship between the two disorders. Not only are patients with epilepsy more likely to experience a DD, but a history of DD preceding the onset of the seizure disorder is more likely to be identified in patients with epilepsy than in a control group. In support of these observations, we review data from animal models of epilepsy showing that decreased activity of serotonin, norepinephrine, dopamine, and GABA facilitate the kindling process of seizure foci, worsen seizure frequency and severity, and are reversed or blocked by antidepressant drugs. Decreased activity of these neurotransmitters is a pivotal pathogenic mechanism of DDs and forms the basis of their pharmacotherapy. Thus, DDs and epilepsy may share common pathogenic mechanisms that facilitate the occurrence of one in the presence of the other. Contrary to long-held beliefs by patients and clinicians alike, in the sense that DDs are a "normal reaction" to the obstacles posed by epilepsy, we review evidence that points to their biologic or endogenous nature. We find a genetic predisposition to DDs, as evidenced by the frequent family history of mood disorders in these patients. Neuroimaging and neuropsychological data support a frontal lobe dysfunction in DDs, and a recent study documents concomitant dysfunction of mesial temporal structures. Depressive disorders have various clinical presentations, some typical of the different types of mood disorders in non-epileptic patients, others constituting rather frequent atypical presentations that can easily go unrecognized. A review of the pharmacologic treatment of DDs in epilepsy highlights the lack of scientific data and points to the empirical form in which these patients have been treated up to the present time. Contrary to clinicians’ fears, most antidepressant drugs are safe in patients with epilepsy.
This article has been cited by other articles:
|
|
 |
|
  A. Mazarati, P. Siddarth, R. A. Baldwin, D. Shin, R. Caplan, and R. Sankar Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine Brain, August 1, 2008; 131(8): 2071 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Sheth and B. E. Gidal Topical Review: Optimizing Epilepsy Management in Teenagers J Child Neurol, April 1, 2006; 21(4): 273 - 279. [Abstract] [PDF]
|
|
|
|
 |
|
 G. A. Baker Depression and suicide in adolescents with epilepsy Neurology, March 28, 2006; 66(66_suppl_3): S5 - S12. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Ferrero, S. Pretta, S. Bertoldi, P. Anserini, V. Remorgida, M. Del Sette, C. Gandolfo, and N. Ragni Increased frequency of migraine among women with endometriosis Hum. Reprod., December 1, 2004; 19(12): 2927 - 2932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Pellock The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy J Child Neurol, August 1, 2004; 19(1_suppl): S1 - S5. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Pellock The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy J Child Neurol, January 1, 2004; 19(1_suppl): S1 - S5. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Kanner and D. W. Dunn Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy J Child Neurol, January 1, 2004; 19(1_suppl): S65 - S72. [Abstract] [PDF]
|
|
|
|
 |
|
 O. Devinsky A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness JAMA, July 16, 2003; 290(3): 381 - 392. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Harden The co-morbidity of depression and epilepsy: Epidemiology, etiology, and treatment Neurology, September 24, 2002; 59(90064): S48 - 55. [Abstract] [Full Text]
|
|
|
|
|
|
R. G. Kaniecki Diagnostic challenges in headache: Migraine as the wolf disguised in sheep's clothing Neurology, May 14, 2002; 58(90096): S1 - 2. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
